Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UPBEAT: Exercise vs Sertraline in CHD with Depression
NCT00302068Phase 3Completed
- Sponsor
- Duke University
- Start
- Jul 2006
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sertraline in major depressive disorder (MDD) (3 arms), sponsored by Duke University. Primary endpoint: Hamilton Depression Rating Scale at 16 weeks. Started Jul 2006; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00302068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00302068.